Target intelligence / Profile preview

Potassium channel subfamily K member 9 (KCNK9) (TASK-3)

Target
TASK-3
Molecular classification
Ion channel, Two-pore domain potassium channel, K2P channel family
01

Overview

Potassium channel subfamily K member 9 (TASK-3) is a pH-sensitive, two-pore domain potassium (K2P) channel that plays a vital role in setting the resting membrane potential and controlling neuronal excitability (UniProt Q9NPC2). It is highly expressed in the central nervous system, particularly within the brainstem's serotonergic neurons of the dorsal raphe nucleus, where it modulates the firing patterns of these cells (PMID: 10801917). TASK-3 channels are sensitive to extracellular acidification, which leads to channel closure and subsequent neuronal depolarization (PMID: 21123634). This mechanism is crucial for physiological processes such as the respiratory response to CO2 and the regulation of sleep-wake cycles. Pathologically, mutations in the KCNK9 gene cause Birk-Barel syndrome, a genomic imprinting disorder, and the channel is frequently overexpressed in various malignancies, promoting tumor cell survival and proliferation (PMID: 25635015). Therapeutic strategies targeting TASK-3 include small-molecule inhibitors like doxapram for respiratory disorders and potential activators for neuroprotection. Because of its role in serotonergic signaling, it is also a target of interest for treating mood disorders and sleep-related breathing issues.

Other names
KCNK9TASK-3TASK3K2P9.1Acid-sensitive potassium channel protein 3
02

Mechanism of action

Modulation of background potassium leak current to regulate membrane potential and cellular excitability.

03

Biological functions

Maintenance of resting membrane potentialRegulation of neuronal excitabilitypH sensingPotassium homeostasis
04

Disease associations

Birk-Barel syndromeCancerDepressionAnxietySleep apneaRespiratory failure
05

Safety considerations

Respiratory depressionOff-target CNS effectsCardiovascular effects via TASK-1/TASK-3 heterodimers
06

Interacting drugs

Doxapram

5 more in the full profile.

07

Biomarkers

KCNK9 gene expression levelspH-dependent potassium current densityKCNK9 gene methylation status

Beyond the preview

Go deeper on Potassium channel subfamily K member 9 (KCNK9) (TASK-3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Potassium channel subfamily K member 9 (KCNK9) (TASK-3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call